BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 21311095)

  • 1. Molecular identification and targeting of colorectal cancer stem cells.
    Kemper K; Grandela C; Medema JP
    Oncotarget; 2010 Oct; 1(6):387-395. PubMed ID: 21311095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD49f-positive cell population efficiently enriches colon cancer-initiating cells.
    Haraguchi N; Ishii H; Mimori K; Ohta K; Uemura M; Nishimura J; Hata T; Takemasa I; Mizushima T; Yamamoto H; Doki Y; Mori M
    Int J Oncol; 2013 Aug; 43(2):425-30. PubMed ID: 23708747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colon cancer stem cells: promise of targeted therapy.
    Todaro M; Francipane MG; Medema JP; Stassi G
    Gastroenterology; 2010 Jun; 138(6):2151-62. PubMed ID: 20420952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Identifications and Clinical Implications of Cancer Stem Cells in Colorectal Cancer.
    Wahab SMR; Islam F; Gopalan V; Lam AK
    Clin Colorectal Cancer; 2017 Jun; 16(2):93-102. PubMed ID: 28237538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of CD44 and CD133 as cancer stem cell markers for colorectal cancer.
    Wang C; Xie J; Guo J; Manning HC; Gore JC; Guo N
    Oncol Rep; 2012 Oct; 28(4):1301-8. PubMed ID: 22895640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a subpopulation of long-term tumor-initiating cells in colon cancer.
    Peng L; Xiong Y; Wang R; Xiang L; Zhou H; Gu H
    Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32729895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FOXM1-Induced PRX3 Regulates Stemness and Survival of Colon Cancer Cells via Maintenance of Mitochondrial Function.
    Song IS; Jeong YJ; Jeong SH; Heo HJ; Kim HK; Bae KB; Park YH; Kim SU; Kim JM; Kim N; Ko KS; Rhee BD; Han J
    Gastroenterology; 2015 Oct; 149(4):1006-16.e9. PubMed ID: 26091938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD133+, CD166+CD44+, and CD24+CD44+ phenotypes fail to reliably identify cell populations with cancer stem cell functional features in established human colorectal cancer cell lines.
    Muraro MG; Mele V; Däster S; Han J; Heberer M; Cesare Spagnoli G; Iezzi G
    Stem Cells Transl Med; 2012 Aug; 1(8):592-603. PubMed ID: 23197865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lgr5+CD44+EpCAM+ Strictly Defines Cancer Stem Cells in Human Colorectal Cancer.
    Leng Z; Xia Q; Chen J; Li Y; Xu J; Zhao E; Zheng H; Ai W; Dong J
    Cell Physiol Biochem; 2018; 46(2):860-872. PubMed ID: 29627827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of cancer stem cells from different grades of human colorectal cancer.
    Manhas J; Bhattacharya A; Agrawal SK; Gupta B; Das P; Deo SV; Pal S; Sen S
    Tumour Biol; 2016 Oct; 37(10):14069-14081. PubMed ID: 27507615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preventive cancer stem cell-based vaccination modulates tumor development in syngeneic colon adenocarcinoma murine model.
    Eini L; Naseri M; Karimi-Busheri F; Bozorgmehr M; Ghods R; Madjd Z
    J Cancer Res Clin Oncol; 2023 Jul; 149(7):4101-4116. PubMed ID: 36040667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression Patterns of Cancer Stem Cell Markers During Specific Celecoxib Therapy in Multistep Rat Colon Carcinogenesis Bioassays.
    Salim EI; Hegazi MM; Kang JS; Helmy HM
    Asian Pac J Cancer Prev; 2016; 17(3):1023-35. PubMed ID: 27039721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stem cell programs in cancer initiation, progression, and therapy resistance.
    Huang T; Song X; Xu D; Tiek D; Goenka A; Wu B; Sastry N; Hu B; Cheng SY
    Theranostics; 2020; 10(19):8721-8743. PubMed ID: 32754274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colon cancer: cancer stem cells markers, drug resistance and treatment.
    Kozovska Z; Gabrisova V; Kucerova L
    Biomed Pharmacother; 2014 Oct; 68(8):911-6. PubMed ID: 25458789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visualization and targeting of LGR5
    Shimokawa M; Ohta Y; Nishikori S; Matano M; Takano A; Fujii M; Date S; Sugimoto S; Kanai T; Sato T
    Nature; 2017 May; 545(7653):187-192. PubMed ID: 28355176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curcumin attenuates resistance to irinotecan via induction of apoptosis of cancer stem cells in chemoresistant colon cancer cells.
    Su P; Yang Y; Wang G; Chen X; Ju Y
    Int J Oncol; 2018 Sep; 53(3):1343-1353. PubMed ID: 29956726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Unique Nonsaccharide Mimetic of Heparin Hexasaccharide Inhibits Colon Cancer Stem Cells via p38 MAP Kinase Activation.
    Boothello RS; Patel NJ; Sharon C; Abdelfadiel EI; Morla S; Brophy DF; Lippman HR; Desai UR; Patel BB
    Mol Cancer Ther; 2019 Jan; 18(1):51-61. PubMed ID: 30337351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stem cells, colorectal cancer and cancer stem cell markers correlations.
    Cherciu I; Bărbălan A; Pirici D; Mărgăritescu C; Săftoiu A
    Curr Health Sci J; 2014; 40(3):153-61. PubMed ID: 25729599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic subpopulations of metastatic colon cancer stem cells: genomic analysis.
    Botchkina IL; Rowehl RA; Rivadeneira DE; Karpeh MS; Crawford H; Dufour A; Ju J; Wang Y; Leyfman Y; Botchkina GI
    Cancer Genomics Proteomics; 2009; 6(1):19-29. PubMed ID: 19451087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colon cancer stem cells: controversies and perspectives.
    Puglisi MA; Tesori V; Lattanzi W; Gasbarrini GB; Gasbarrini A
    World J Gastroenterol; 2013 May; 19(20):2997-3006. PubMed ID: 23716979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.